nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A niche-dependent myeloid transcriptome signature defines dormant myeloma cells
|
Khoo, Weng Hua |
|
|
134 |
1 |
p. 30-43 |
artikel |
2 |
An unusual cause of lymphadenopathy: when AFB staining is not enough
|
Cassidy, Daniel P. |
|
|
134 |
1 |
p. 93 |
artikel |
3 |
A population of CD20+CD27+CD43+CD38lo/int B1 cells in PNH are missing GPI-anchored proteins and harbor PIGA mutations
|
Kageyama, Yuki |
|
|
134 |
1 |
p. 89-92 |
artikel |
4 |
Artuso I, Lidonnici MR, Altamura S, et al. Transferrin receptor 2 is a potential novel therapeutic target for β-thalassemia: evidence from a murine model. Blood. 2018;132(21):2286-2297.
|
|
|
|
134 |
1 |
p. 94 |
artikel |
5 |
Chronic lymphocytic leukemia cells impair mitochondrial fitness in CD8+ T cells and impede CAR T-cell efficacy
|
van Bruggen, Jaco A.C. |
|
|
134 |
1 |
p. 44-58 |
artikel |
6 |
Dasmahapatra G, Lembersky D, Kramer L, Fisher RI, Friedberg J, Dent P, Grant S. The pan-HDAC inhibitor vorinostat potentiates the activity of the proteasome inhibitor carfilzomib in human DLBCL cells in vitro and in vivo. Blood. 2010;115(22):4478-4487.
|
|
|
|
134 |
1 |
p. 95 |
artikel |
7 |
Dasmahapatra G, Rahmani M, Dent P, Grant S. The tyrphostin adaphostin interacts synergistically with proteasome inhibitors to induce apoptosis in human leukemia cells through a reactive oxygen species (ROS)–dependent mechanism. Blood. 2006;107(1):232-240.
|
|
|
|
134 |
1 |
p. 95 |
artikel |
8 |
Editorial Board
|
|
|
|
134 |
1 |
p. i |
artikel |
9 |
Modeling the safe minimum frequency of molecular monitoring for CML patients attempting treatment-free remission
|
Shanmuganathan, Naranie |
|
|
134 |
1 |
p. 85-89 |
artikel |
10 |
Myeloma sleeper agent in myeloid disguise
|
Dhakal, Binod |
|
|
134 |
1 |
p. 3-4 |
artikel |
11 |
Nguyen TD, Shaid S, Vakhrusheva O, et al. Loss of the selective autophagy receptor p62 impairs murine myeloid leukemia progression and mitophagy. Blood. 2019;133(2):168-179.
|
|
|
|
134 |
1 |
p. 94 |
artikel |
12 |
Osteopontin makes the bridge in TRALI
|
Boilard, Eric |
|
|
134 |
1 |
p. 4-6 |
artikel |
13 |
Osteopontin mediates murine transfusion-related acute lung injury via stimulation of pulmonary neutrophil accumulation
|
Kapur, Rick |
|
|
134 |
1 |
p. 74-84 |
artikel |
14 |
PD-1 blockade with pembrolizumab for classical Hodgkin lymphoma after autologous stem cell transplantation
|
Armand, Philippe |
|
|
134 |
1 |
p. 22-29 |
artikel |
15 |
Pediatric Evans syndrome is associated with a high frequency of potentially damaging variants in immune genes
|
Hadjadj, Jérôme |
|
|
134 |
1 |
p. 9-21 |
artikel |
16 |
Revving up the immune engine in cHL
|
Karmali, Reem |
|
|
134 |
1 |
p. 1-2 |
artikel |
17 |
RUNX1-targeted therapy for AML expressing somatic or germline mutation in RUNX1
|
Mill, Christopher P. |
|
|
134 |
1 |
p. 59-73 |
artikel |
18 |
Yet do much less...so much less!
|
Lipton, Jeffrey H. |
|
|
134 |
1 |
p. 6-7 |
artikel |